PP
AVXL icon

Paloma Partners’s Anavex Life Sciences AVXL Stock Holding History

Paloma Partners’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,033
Closed -$275K – 1083
2021
Q2 		$275K Buy
+12,033
New +$178K 0.01% 1359
2018
Q3 		– Sell
-191,571
Closed -$502K – 1536
2018
Q2 		$502K Buy
+191,571
New +$535K 0.01% 1036

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paloma Partners's AVXL Position: Q3 2021 in Review

Paloma Partners sold out of Anavex Life Sciences (AVXL) in Q3 2021, closing a stake of 12,033 shares — an estimated $275K sold.

Paloma Partners first reported a position in AVXL in Q2 2018 and held it in 2 quarters. The position peaked at $502K in Q2 2018. 136 funds tracked by Wall St. Rank hold AVXL as of Q3 2021.

  • Paloma Partners reported no remaining Anavex Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Paloma Partners sold 12,033 Anavex Life Sciences shares in Q3 2021, an estimated $275K.
  • Paloma Partners first reported a position in Anavex Life Sciences in Q2 2018 and held it in 2 quarters.
  • Paloma Partners's Anavex Life Sciences position peaked at $502K in Q2 2018.
  • 136 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.